Aurora Labs Limited Logo

Aurora Labs Limited

A3D.AX

(1.2)
Stock Price

0,06 AUD

-136% ROA

-276.54% ROE

-2.37x PER

Market Cap.

7.855.619,00 AUD

4.48% DER

0% Yield

-1350.6% NPM

Aurora Labs Limited Stock Analysis

Aurora Labs Limited Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Aurora Labs Limited Fundamental Stock Analysis
# Analysis Rating
1 DER

The stock has a low debt to equity ratio (4%), which means it has a small amount of debt compared to the ownership it holds

2 Revenue Growth

Over the past three years, this company's revenue has consistently grown, demonstrating a positive financial trend that makes it an appealing choice.

3 Net Profit Growth

Throughout the last three years, this company has experienced consistent net profit growth, reflecting a robust financial performance and making it an attractive investment prospect.

4 Graham Number

The Graham number calculation reveals that this company's stock price is potentially underestimated, implying that it may be a promising investment option.

5 ROE

Negative ROE (-144.84%) indicates poor financial performance, raising concerns about profitability and efficiency in utilizing shareholders' equity.

6 ROA

The stock's ROA (-136%) suggests that it's struggling to generate profits from its assets, making it a risky choice for investment.

7 PBV

The stock's high Price-to-Book Value (P/BV) ratio (3.52x) suggests it's overvalued, potentially making it an expensive investment.

8 Assets Growth

Regrettably, this company's revenue has shown no signs of growth over the past three years, suggesting limited potential for returns and making it a less appealing choice.

9 Dividend Growth

The company's dividend growth has remained unchanged for three years, signaling a lack of positive momentum and making it a less favorable investment choice.

10 Dividend

The company has not distributed any dividends in the past three years, which may raise concerns for investors looking for regular income from their investments.

11 Buffet Intrinsic Value

The company's stock appears overvalued (0) by Warren Buffett's formula, suggesting a less favorable investment opportunity as its market price exceeds its estimated intrinsic value.

Aurora Labs Limited Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Aurora Labs Limited Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Sell
2 MACD Sell
3 RSI Hold
4 Stoch RSI Hold

Aurora Labs Limited Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Aurora Labs Limited Revenue
Year Revenue Growth
2015 0
2016 0 0%
2017 237.995 100%
2018 329.970 27.87%
2019 841.620 60.79%
2020 414.860 -102.87%
2020 414.860 0%
2021 171.618 -141.73%
2022 32.195 -433.06%
2023 134.564 76.07%
2024 174.160 22.74%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Aurora Labs Limited Research and Development Expenses
Year Research and Development Expenses Growth
2015 200.593
2016 280.168 28.4%
2017 504.592 44.48%
2018 1.321.085 61.8%
2019 2.297.536 42.5%
2020 1.241.016 -85.13%
2020 1.255.816 1.18%
2021 451.448 -178.18%
2022 359.974 -25.41%
2023 212.340 -69.53%
2024 449.926 52.81%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Aurora Labs Limited General and Administrative Expenses
Year General and Administrative Expenses Growth
2015 0
2016 210.332 100%
2017 432.037 51.32%
2018 811.870 46.78%
2019 1.137.887 28.65%
2020 5.188.867 78.07%
2020 1.436.487 -261.22%
2021 514.900 -178.98%
2022 591.580 12.96%
2023 405.466 -45.9%
2024 0 0%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Aurora Labs Limited EBITDA
Year EBITDA Growth
2015 39
2016 -1.203.530 100%
2017 -4.826.752 75.07%
2018 -6.984.722 30.9%
2019 -9.473.046 26.27%
2020 -8.897.911 -6.46%
2020 -9.078.490 1.99%
2021 -4.040.400 -124.69%
2022 -3.746.580 -7.84%
2023 -3.363.390 -11.39%
2024 -3.186.090 -5.56%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Aurora Labs Limited Gross Profit
Year Gross Profit Growth
2015 0
2016 -2.392 100%
2017 83.933 102.85%
2018 213.278 60.65%
2019 501.294 57.45%
2020 173.020 -189.73%
2020 -4.956.654 103.49%
2021 -2.083.919 -137.85%
2022 -2.413.016 13.64%
2023 -2.524.195 4.4%
2024 -2.218.273 -13.79%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Aurora Labs Limited Net Profit
Year Net Profit Growth
2015 -272.152
2016 -1.118.866 75.68%
2017 -3.398.989 67.08%
2018 -5.531.257 38.55%
2019 -7.643.073 27.63%
2020 -8.155.859 6.29%
2020 -8.155.858 -0%
2021 -4.422.697 -84.41%
2022 -3.148.534 -40.47%
2023 -2.961.856 -6.3%
2024 -2.806.012 -5.55%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Aurora Labs Limited Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2015 0
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2024 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Aurora Labs Limited Free Cashflow
Year Free Cashflow Growth
2014 -273.006
2015 0 0%
2016 -4.160.312 100%
2017 -6.115.243 31.97%
2018 -8.184.301 25.28%
2019 -6.883.963 -18.89%
2020 -1.671.544 -311.83%
2021 -3.028.048 44.8%
2022 -774.120 -291.16%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Aurora Labs Limited Operating Cashflow
Year Operating Cashflow Growth
2014 -272.152
2015 0 0%
2016 -3.652.918 100%
2017 -5.531.257 33.96%
2018 -7.763.069 28.75%
2019 -6.289.349 -23.43%
2020 -1.668.832 -276.87%
2021 -2.979.629 43.99%
2022 -768.966 -287.49%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Aurora Labs Limited Capital Expenditure
Year Capital Expenditure Growth
2014 854
2015 0 0%
2016 507.394 100%
2017 583.986 13.12%
2018 421.232 -38.64%
2019 594.614 29.16%
2020 2.712 -21825.29%
2021 48.419 94.4%
2022 5.154 -839.45%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Aurora Labs Limited Equity
Year Equity Growth
2014 -164.848
2015 3.351.710 104.92%
2016 6.775.662 50.53%
2017 6.446.642 -5.1%
2018 5.735.996 -12.39%
2019 3.390.228 -69.19%
2020 2.200.587 -54.06%
2021 2.631.382 16.37%
2022 1.458.408 -80.43%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Aurora Labs Limited Assets
Year Assets Growth
2014 105.132
2015 3.778.884 97.22%
2016 7.774.821 51.4%
2017 7.238.841 -7.4%
2018 8.024.947 9.8%
2019 5.040.824 -59.2%
2020 2.911.788 -73.12%
2021 3.347.961 13.03%
2022 2.177.758 -53.73%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Aurora Labs Limited Liabilities
Year Liabilities Growth
2014 249.980
2015 427.174 41.48%
2016 999.159 57.25%
2017 792.199 -26.12%
2018 2.288.951 65.39%
2019 1.650.596 -38.67%
2020 711.201 -132.09%
2021 716.579 0.75%
2022 719.350 0.39%

Aurora Labs Limited Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
0
Net Income per Share
-0.01
Price to Earning Ratio
-2.37x
Price To Sales Ratio
58.38x
POCF Ratio
-2.74
PFCF Ratio
-3.04
Price to Book Ratio
4.81
EV to Sales
51.53
EV Over EBITDA
-2.01
EV to Operating CashFlow
-2.71
EV to FreeCashFlow
-2.68
Earnings Yield
-0.42
FreeCashFlow Yield
-0.33
Market Cap
0,01 Bil.
Enterprise Value
0,01 Bil.
Graham Number
0.04
Graham NetNet
0

Income Statement Metrics

Net Income per Share
-0.01
Income Quality
0.86
ROE
-7.35
Return On Assets
-2.29
Return On Capital Employed
-3.84
Net Income per EBT
0.83
EBT Per Ebit
1.01
Ebit per Revenue
-15.97
Effective Tax Rate
0.17

Margins

Sales, General, & Administrative to Revenue
3.01
Research & Developement to Revenue
1.58
Stock Based Compensation to Revenue
0.24
Gross Profit Margin
-11.14
Operating Profit Margin
-15.97
Pretax Profit Margin
-16.18
Net Profit Margin
-13.51

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
-0.01
Free CashFlow per Share
-0.01
Capex to Operating CashFlow
0.01
Capex to Revenue
-0.17
Capex to Depreciation
-0.14
Return on Invested Capital
-2.58
Return on Tangible Assets
-1.36
Days Sales Outstanding
1854.61
Days Payables Outstanding
508.22
Days of Inventory on Hand
0
Receivables Turnover
0.2
Payables Turnover
0.72
Inventory Turnover
0
Capex per Share
-0

Balance Sheet

Cash per Share
0,00
Book Value per Share
0,01
Tangible Book Value per Share
0.01
Shareholders Equity per Share
0.01
Interest Debt per Share
0
Debt to Equity
0.04
Debt to Assets
0.03
Net Debt to EBITDA
0.27
Current Ratio
2.42
Tangible Asset Value
0,00 Bil.
Net Current Asset Value
0,00 Bil.
Invested Capital
0.04
Working Capital
0,00 Bil.
Intangibles to Total Assets
0
Average Receivables
0,00 Bil.
Average Payables
0,00 Bil.
Average Inventory
0
Debt to Market Cap
0.01

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Aurora Labs Limited Dividends
Year Dividends Growth

Aurora Labs Limited Profile

About Aurora Labs Limited

Aurora Labs Limited engages in the design, development, and commercialization of 3D metal printers, powders, and digital parts and its related intellectual property in Australia. It develops industrial grade 3D metal printers. The company was incorporated in 2014 and is based in Canning Vale, Australia.

CEO
Rebekah Letheby
Employee
15
Address
2/79 Bushland Ridge, Bibra Lake
Perth, 6155

Aurora Labs Limited Executives & BODs

Aurora Labs Limited Executives & BODs
# Name Age
1 Mr. John Henry
Business Development & Marketing Director
70
2 Rebekah Letheby
Chief Executive Officer
70
3 Mr. Grant Jonathan Mooney BBus, C.A., CA
Non-Executive Chairman & Company Secretary
70

Aurora Labs Limited Competitors